FcRγ-chain ITAM signaling is critically required for cross-presentation of soluble antibody-antigen complexes by dendritic cells

Journal of Immunology

Volumn 193, Issue 11, 2014, Pages 5506-5514

  Boross, Peter ^a   Van Montfoort, Nadine ^b,d   Stapels, Daphne A C ^a   Van Der Poel, Cees E ^a   Bertens, Christian ^a   Meeldijk, Jan ^a,c   Marco Jansen, J H ^a   Sjef Verbeek, J ^b   Ossendorp, Ferry ^b   Wubbolts, Richard ^c   Leusen, Jeanette H W ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MEMBRANE PROTEIN; PROTEIN ITAM; UNCLASSIFIED DRUG; ANTIGEN ANTIBODY COMPLEX; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; LEUKOCYTE ANTIGEN;

ANIMAL CELL; ANTIGEN ANTIBODY COMPLEX; ANTIGEN PRESENTATION; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CROSS PRESENTATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; IMMUNOREACTIVITY; INTERNALIZATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; OPSONIZATION; PHAGOCYTOSIS; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; STREPTOCOCCUS PNEUMONIAE; UPREGULATION; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL DIFFERENTIATION; ENDOCYTOSIS; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; METABOLISM; PROTEIN TERTIARY STRUCTURE; TRANSGENIC MOUSE;

ANIMALS; ANTIGEN-ANTIBODY COMPLEX; ANTIGENS, CD; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELLS, CULTURED; CROSS-PRIMING; DENDRITIC CELLS; ENDOCYTOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, IGG; SIGNAL TRANSDUCTION;

EID: 84912550494     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302012     Document Type: Article

References (33)

1. Schuurhuis, D. H., N. van Montfoort, A. Ioan-Facsinay, R. Jiawan, M. Camps, J. Nouta, C. J. Melief, J. S. Verbeek, and F. Ossendorp. 2006. Immune complexloaded dendritic cells are superior to soluble immune complexes as antitumor vaccine. J. Immunol. 176: 4573-4580.
2. Kalergis, A. M., and J. V. Ravetch. 2002. Inducing tumor immunity through the selective engagement of activating Fcgamma receptors on dendritic cells. J. Exp. Med. 195: 1653-1659.
3. Regnault, A., D. Lankar, V. Lacabanne, A. Rodriguez, C. Thé ry, M. Rescigno, T. Saito, S. Verbeek, C. Bonnerot, P. Ricciardi-Castagnoli, and S. Amigorena. 1999. Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J. Exp. Med. 189: 371-380.
4. van Montfoort, N., S. M. Mangsbo, M. G. Camps, W. W. van Maren, I. E. Verhaart, A. Waisman, J. W. Drijfhout, C. J. Melief, J. S. Verbeek, and F. Ossendorp. 2012. Circulating specific antibodies enhance systemic crosspriming by delivery of complexed antigen to dendritic cells in vivo. Eur. J. Immunol. 42: 598-606.
5. Nimmerjahn, F., and J. V. Ravetch. 2008. Fcgamma receptors as regulators of immune responses. Nat. Rev. Immunol. 8: 34-47.
6. Ivashkiv, L. B. 2009. Cross-regulation of signaling by ITAM-associated receptors. Nat. Immunol. 10: 340-347.
7. Rafiq, K., A. Bergtold, and R. Clynes. 2002. Immune complex-mediated antigen presentation induces tumor immunity. J. Clin. Invest. 110: 71-79.
8. van Montfoort, N., P. A. 't Hoen, S. M. Mangsbo, M. G. Camps, P. Boross, C. J. Melief, F. Ossendorp, and J. S. Verbeek. 2012. Fcγ receptor IIb strongly regulates Fcγ receptor-facilitated T cell activation by dendritic cells. J. Immunol. 189: 92-101.
9. Joffre, O. P., E. Segura, A. Savina, and S. Amigorena. 2012. Cross-presentation by dendritic cells. Nat. Rev. Immunol. 12: 557-569.
10. van Montfoort, N., M. G. Camps, S. Khan, D. V. Filippov, J. J. Weterings, J. M. Griffith, H. J. Geuze, T. van Hall, J. S. Verbeek, C. J. Melief, and F. Ossendorp. 2009. Antigen storage compartments in mature dendritic cells facilitate prolonged cytotoxic T lymphocyte cross-priming capacity. Proc. Natl. Acad. Sci. USA 106: 6730-6735.
11. Sedlik, C., D. Orbach, P. Veron, E. Schweighoffer, F. Colucci, R. Gamberale, A. Ioan-Facsinay, S. Verbeek, P. Ricciardi-Castagnoli, C. Bonnerot, et al. 2003. A critical role for Syk protein tyrosine kinase in Fc receptor-mediated antigen presentation and induction of dendritic cell maturation. J. Immunol. 170: 846-852.
12. Mócsai, A., C. L. Abram, Z. Jakus, Y. Hu, L. L. Lanier, and C. A. Lowell. 2006. Integrin signaling in neutrophils and macrophages uses adaptors containing immunoreceptor tyrosine-based activation motifs. Nat. Immunol. 7: 1326-1333.
13. de Haij, S., J. H. Jansen, P. Boross, F. J. Beurskens, J. E. Bakema, D. L. Bos, A. Martens, J. S. Verbeek, P. W. Parren, J. G. van de Winkel, and J. H. Leusen. 2010. In vivo cytotoxicity of type I CD20 antibodies critically depends on Fc receptor ITAM signaling. Cancer Res. 70: 3209-3217.
14. Winzler, C., P. Rovere, M. Rescigno, F. Granucci, G. Penna, L. Adorini, V. S. Zimmermann, J. Davoust, and P. Ricciardi-Castagnoli. 1997. Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J. Exp. Med. 185: 317-328.
15. Sanderson, S., and N. Shastri. 1994. LacZ inducible, antigen/MHC-specific T cell hybrids. Int. Immunol. 6: 369-376.
16. Rodríguez, M. E., W. L. Van der Pol, and J. G. J. Van de Winkel. 2001. Flow cytometry-based phagocytosis assay for sensitive detection of opsonic activity of pneumococcal capsular polysaccharide antibodies in human sera. J. Immunol. Methods 252: 33-44.
17. Linkert, M., C. T. Rueden, C. Allan, J. M. Burel, W. Moore, A. Patterson, B. Loranger, J. Moore, C. Neves, D. Macdonald, et al. 2010. Metadata matters: access to image data in the real world. J. Cell Biol. 189: 777-782.
18. Takai, T., M. Li, D. Sylvestre, R. Clynes, and J. V. Ravetch. 1994. FcR gamma chain deletion results in pleiotrophic effector cell defects. Cell 76: 519-529.
19. Burgdorf, S., A. Kautz, V. Böhnert, P. A. Knolle, and C. Kurts. 2007. Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation. Science 316: 612-616.
20. Ukkonen, P., V. Lewis, M. Marsh, A. Helenius, and I. Mellman. 1986. Transport of macrophage Fc receptors and Fc receptor-bound ligands to lysosomes. J. Exp. Med. 163: 952-971.
21. Bonnerot, C., V. Briken, and S. Amigorena. 1997. Intracellular signaling and endosomal trafficking of immunoreceptors: shared effectors underlying MHC class II-restricted antigen presentation. Immunol. Lett. 57: 1-4.
22. Kleijmeer, M. J., J. M. Escola, F. G. UytdeHaag, E. Jakobson, J. M. Griffith, A. D. Osterhaus, W. Stoorvogel, C. J. Melief, C. Rabouille, and H. J. Geuze. 2001. Antigen loading of MHC class I molecules in the endocytic tract. Traffic 2: 124-137.
23. Savina, A., C. Jancic, S. Hugues, P. Guermonprez, P. Vargas, I. C. Moura, A. M. Lennon-Duménil, M. C. Seabra, G. Raposo, and S. Amigorena. 2006. NOX2 controls phagosomal pH to regulate antigen processing during crosspresentation by dendritic cells. Cell 126: 205-218.
24. Khan, S., M. S. Bijker, J. J. Weterings, H. J. Tanke, G. J. Adema, T. van Hall, J. W. Drijfhout, C. J. Melief, H. S. Overkleeft, G. A. van der Marel, et al. 2007. Distinct uptake mechanisms but similar intracellular processing of two different Toll-like receptor ligand-peptide conjugates in dendritic cells. J. Biol. Chem. 282: 21145-21159.
25. Zom, G. G., S. Khan, D. V. Filippov, and F. Ossendorp. 2012. TLR ligandpeptide conjugate vaccines: toward clinical application. Adv. Immunol. 114: 177-201.
26. Ossendorp, F., N. Fu, M. Camps, F. Granucci, S. J. Gobin, P. J. van den Elsen, D. Schuurhuis, G. J. Adema, G. B. Lipford, T. Chiba, et al. 2005. Differential expression regulation of the alpha and beta subunits of the PA28 proteasome activator in mature dendritic cells. J. Immunol. 174: 7815-7822.
27. van Lent, P., K. C. Nabbe, P. Boross, A. B. Blom, J. Roth, A. Holthuysen, A. Sloetjes, S. Verbeek, and W. van den Berg. 2003. The inhibitory receptor FcgammaRII reduces joint inflammation and destruction in experimental immune complex-mediated arthritides not only by inhibition of FcgammaRI/III but also by efficient clearance and endocytosis of immune complexes. Am. J. Pathol. 163: 1839-1848.
28. Dhodapkar, K. M., D. Banerjee, J. Connolly, A. Kukreja, E. Matayeva, M. C. Veri, J. V. Ravetch, R. M. Steinman, andM. V. Dhodapkar. 2007. Selective blockade of the inhibitory Fcgamma receptor (FcgammaRIIB) in human dendritic cells and monocytes induces a type I interferon response program. J. Exp. Med. 204: 1359-1369.
29. Flores, M., D. D. Desai, M. Downie, B. Liang, M. P. Reilly, S. E. McKenzie, and R. Clynes. 2009. Dominant expression of the inhibitory FcgammaRIIB prevents antigen presentation by murine plasmacytoid dendritic cells. J. Immunol. 183: 7129-7139.
30. van Vugt, M. J., M. J. Kleijmeer, T. Keler, I. Zeelenberg, M. A. van Dijk, J. H. Leusen, H. J. Geuze, and J. G. van de Winkel. 1999. The FcgammaRIa (CD64) ligand binding chain triggers major histocompatibility complex class II antigen presentation independently of its associated FcR gamma-chain. Blood 94: 808-817.
31. van der Poel, C. E., R. M. Spaapen, J. G. van de Winkel, and J. H. Leusen. 2011. Functional characteristics of the high affinity IgG receptor, FcγRI. J. Immunol. 186: 2699-2704.
32. Amigorena, S. 2002. Fc gamma receptors and cross-presentation in dendritic cells. J. Exp. Med. 195: F1-F3.
33. den Dunnen, J., S. I. Gringhuis, and T. B. Geijtenbeek. 2010. Dusting the sugar fingerprint: C-type lectin signaling in adaptive immunity. Immunol. Lett. 128: 12-16.